levodopa
AssetAlso Levodopa inhalation powder, Inbrija®
Inhaled dopamine precursor converting to dopamine in the brain to treat OFF episodes
- Stage
- Approved
- Modality
- Small molecule
- Target
- Not known
- 3
- Indications
- 125
- Trials
- 1
- Developer
Indications
3Parkinson
Approved, ema.europa.eu, 9 Oct 2026
Parkinson's disease
Approved, accessdata.fda.gov, 9 Oct 2026
Off episodes of Parkinson disease
Human trials, Recruiting, NCT07797790, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials125
- Evidence for its targets1
- Competitors12
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 9 Oct 2026, 7 sources